Geranylgeranylacetone inhibits ovarian cancer progression in vitro and in vivo.

Kae Hashimoto; Ken-ichirou Morishige; Kenjiro Sawada; Seiji Ogata; Masahiro Tahara; Shoko Shimizu; Masahiro Sakata; Keiichi Tasaka; Tadashi Kimura

doi:10.1016/j.bbrc.2007.02.102

Geranylgeranylacetone inhibits ovarian cancer progression in vitro and in vivo.

Identifier:nobleid.org/w1/20260515/D643E855

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/D643E855.svg?ark=w1%2F20260515%2FD643E855)](https://nobleid.org/work/w1/20260515/D643E855)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Kae Hashimoto

Ken-ichirou Morishige

Claim authorship of this work

Geranylgeranylacetone inhibits ovarian cancer progression in vitro and in vivo.

Identifier:nobleid.org/w1/20260515/D643E855

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/D643E855.svg?ark=w1%2F20260515%2FD643E855)](https://nobleid.org/work/w1/20260515/D643E855)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Kae Hashimoto

Ken-ichirou Morishige

Claim authorship of this work